A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan.

Abstract

This research was originally published in The Journal of Biological Chemistry. Noriko Toyama-Sorimachi, Hiroyuki Sorimachi, Yoshimi Tobita, Fujiko Kitamura, Hideo Yagita, Koichi Suzuki and Masayuki Miyasaka. A Novel Ligand for CD44 Is Serglycin, a Hematopoietic Cell Lineage-specific Proteoglycan : POSSIBLE INVOLVEMENT IN LYMPHOID CELL ADHERENCE AND ACTIVATION. The Journal of Biological Chemistry. 1995; Vol.270:pp7437-pp7444. © the American Society for Biochemistry and Molecular Biology